Main Article Content
Objective: To survey the use of carbapenem antibiotics at Can Tho Children’s Hospital. Objects and methods: Retrospective-descriptive study on 140 medical records of patients being treated at departments of Can Tho Children’s Hospital during the period from June 1st, 2020 to December 31st, 2020. Results: 26.43% of carbapenems were indicated empirically initiate, 73.57% of carbapenem was indicated in alternative regimens as the presence of microbiological results or worsened or impaired patient status. Carbapenem was mainly used in combination regimens. The proportion of the combination in the initiation regimen was 100%. In which, the proportion of combination regimen between carbapenem and an antibiotic (or vancomycin or gentamicin) was mainly. The rate of combination of three antibiotics was 18.9%. In the replacement regimen, the proportion of combination regimen was 79.6%. Of these, 57.3% of the carbapenem was combined with another antibiotic, most of which was combined with vancomycin. Combination regimen of three or four antibiotics accounted for a low percentage. Conclusion: 26.43% of carbapenem was indicated empirically initiate, 73.57% of carbapenem was indicated in an alternative regimen in the presence of microbiological results or worsened or impaired patient status. Carbapenem was mainly used in combination regimens.
Current situation of using antibiotics, carbapenem
2. Verwaest C, Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit, Clin Microbiol Infect, 2000; 6(6): 294-302
3. Minh NTL, Evaluation of the use of carbapenem antibiotics at Bach Mai hospital, Master's thesis in pharmacology, Hanoi University of Pharmacy, 2013. (in Vietnamese)
4. Van PH, Binh PT, Antibiotics: Antibiotic resistance Antibiogram technique Basic problems, Medical Publishing House, 2013; p. 19-24. (in Vietnamese)
5. Tumbarello M, Trecarichi EM, Francesco GDR et al., Infections caused by KPCproducing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study, J Antimicrob Chemother, 2015; 70(7): 2133-2143.
6. Daikos GL, Tsaousi S, Tzouvelekis LS et al., Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems, Antimicrob Agents Chemother, 2014; 58(4): 2322-2328.
7. Lee CR, Cho IH, Jeong BC et al., Strategies to minimize antibiotic resistance, Int J Environ Res Public Health, 2013; 10(9): 4274-4305.
8. Qureshi ZA, Paterson DL, Potoski BA, et al., Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens, Antimicrob Agents Chemother, 2012; 56(4): 2108-2113.
9. Anh NTT, Analysis of the use of carbapenem antibiotics in the emergency department, Thanh Hoa Children's Hospital, Thesis of a specialist pharmacist at level 1, Hanoi University of Pharmacy. Presented in Hanoi, Vietnam, 2017.